CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired Celsis Group Limited for $214.5 million, a transaction completed in July 2015, structured as all cash.
Celsis Group Limited operates in Manufacturing Support — Microbial Solutions, is based in United Kingdom. Celsis Group Limited was a leading provider of rapid testing systems for non-sterile bacterial contamination for the biopharmaceutical and consumer products industries.
The purpose of this acquisition was to enhance our portfolio of rapid microbial detection products and services with the addition of a rapid bioburden testing product. The purchase price for Celsis was $214.5 million.
Microbial Solutions, Manufacturing Support segment
In July 2015, we acquired Celsis Group Limited (Celsis), a leading provider of rapid testing systems for non-sterile bacterial contamination for the biopharmaceutical and consumer products industries. The purpose of this acquisition was to enhance our portfolio of rapid microbial detection products and services with the addition of a rapid bioburden testing product. The purchase price for Celsis was $214.5 million.Charles River FY2015 10-K, Business Acquisitions note
Advisory firms were not disclosed for this transaction.